Stem cell factor (SCF) and hepatocyte growth factor (HGF) were more elevated in affected CIDP patients than in GBS patients and are considered as indicators for chronicity serving as supplementary diagnostic and monitoring biomarkers [71]. Here, HGF is linked to Guillain-Barre syndrome.